Federal appeals court overturns $137M patent verdict against Roche — but the case isn't closed just yet
A federal appeals court overturned a $137 million verdict against Roche Diagnostics on Friday in a Delaware patent infringement case — but the pharma giant isn’t completely out of the woods.
While the court ruled that Roche did not induce customers to use its Cobas diagnostics machines in a way that infringed upon three Meso Scale patents, it maintained that Roche directly infringed upon one of its patents, and ordered a new damages trial.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
